Medical News

RSS

Angelica sinensis polysaccharides alleviate neuronal cell injury caused by oxidative stress

According to traditional Chinese medicine, the roles of Angelica sinensis correlate with tonifying the blood and promoting its circulation. Recent studies have shown that extracts of Angelica sinensis have antioxidative and neuroprotective effects.

10 Apr 2014

Human testes respond differently to endocrine disrupting chemicals

Human and rat testes respond differently to endocrine disrupting chemicals such as BPA in two thirds of all cases, according to a recent review. As human safety levels are extrapolated from rodent data, the study could lead to a re-evaluation of the acceptable daily intake for many endocrine disruptors.

10 Apr 2014

Study: CD206-targeting Manocept platform may provide potential avenues to enhance diagnosis in Kaposi Sarcoma

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that collaborators from the University of California, San Francisco (UCSF) presented results at the 2014 American Association for Cancer Research (AACR) conference, April 5-9, 2014 in San Diego, CA, highlighting the potential utility of imaging agents derived from Navidea's Manocept™ platform in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma (KS).

10 Apr 2014

Lemelson-MIT Program announces winners of National Collegiate Student Prize Competition

The Lemelson-MIT Program today announced winners of the Lemelson-MIT National Collegiate Student Prize Competition (NCSPC), a nationwide search for the most inventive undergraduate and graduate students.

10 Apr 2014

Shiseido concludes joint venture agreement to expand Indonesia operations

Shiseido has concluded a joint venture agreement with PT Sinar Mas Tunggal, a group company of the Indonesian conglomerate, Sinar Mas Group.

10 Apr 2014

BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.

10 Apr 2014

CNO features in Forbes 2014 list of 50 Most Trustworthy Financial Companies in America

CNO Financial Group, Inc. (NYSE: CNO) , the holding company for several national life and health insurers that serve middle-income working Americans and retirees, earned a place on the prestigious Forbes 2014 list of the 50 Most Trustworthy Financial Companies in America.

10 Apr 2014

Inserm plays key role in developing European research

The French National Institute of Health and Medical Research (Inserm) is currently the leading biomedical research organisation in Europe, and plays a key role in developing European research. To mark its 50th anniversary, Inserm wanted to assess the perceptions of Europeans regarding biomedical research.

10 Apr 2014

Quantum Materials supplies metallic oxide particles to major Asian electronics conglomerate

Quantum Materials Corp. (OTCQB:QTMM) announced today shipping size-optimized metallic oxide particles to a major Asian electronics conglomerate.

10 Apr 2014

New discovery opens door to development of new treatments that stop progression of Parkinson's disease

A research led by the Research Institute Vall d'Hebron (VHIR), in which the University of Valencia participated, has shown that pathological forms of the α-synuclein protein present in deceased patients with Parkinson's disease are able to initiate and spread in mice and primates the neurodegenerative process that typifies this disease.

10 Apr 2014

AVEO joins with Biodesix to develop and commercialize ficlatuzumab for treatment of NSCLC

AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced that they have entered into a worldwide agreement to develop and commercialize AVEO's hepatocyte growth factor (HGF) inhibitory antibody ficlatuzumab, with a Biodesix® companion diagnostic test.

10 Apr 2014

Rite Aid announces acquisition of Houston-based RediClinic

Rite Aid Corporation announced today it has acquired Houston-based RediClinic, one of the nation's leading operators of retail clinics. RediClinic currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Through the acquisition, RediClinic will operate as a wholly owned subsidiary of Rite Aid. Details of the transaction were not disclosed.

10 Apr 2014

NextGen earns ONC 2014 Edition criteria certification for Emergency Department Solution

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today that NextGen® Emergency Department Solution version 6.0 is compliant with the ONC 2014 Edition criteria and was certified as an electronic health record (EHR) Module on March 7, 2014 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ACB, in accordance with the applicable Hospital certification criteria adopted by the Secretary of Health and Human Services.

10 Apr 2014

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.

10 Apr 2014

Sealand Natural Resources expands into new markets to support consumer demands

Sealand Natural Resources Inc. (OTCBB:SLNR), a new product development company which manufactures, markets and sells functional beverages (Sealand BIRK), today announced global expansion into new markets worldwide to support consumer demands.

10 Apr 2014

Spike in mortality after cardiac surgery is associated with 30 days survival measurement

Analyzing a national database of hospital inpatient records, a team of researchers reports an expected spike in mortality six days after cardiac surgery, but also a more surprising and potentially troubling jump in deaths at the 30-day mark.

10 Apr 2014

Affordable Care Act may alter costs for Automobile and liability insurance

The expansion of health insurance accomplished under the Affordable Care Act may alter costs for several major types of liability insurance, although any such changes are likely to be modest, according to a new RAND Corporation report.

10 Apr 2014

Life-space mobility reflects physical function and sense of autonomy in older adults

Physical function and sense of autonomy are independent determinants of life-space mobility in older people. This was found in a study conducted at the Gerontology Research Center of the University of Jyv-skyl-. In this project, 848 older men and women that lived independently in the Jyv-skyl- region in Central Finland were interviewed at their own home.

10 Apr 2014

Researchers examine mental health toll exacted on civilians who work with military in war zones

The punishing psychological toll endured by military personnel in war zones has been extensively documented for years by researchers, perhaps more than ever in the wake of recent military engagements in Iraq and Afghanistan.

10 Apr 2014

Novel prediction model improves patient outcomes after paracetamol-induced acute liver failure

In the UK paracetamol toxicity is the most common cause of ALF and has a high mortality rate. It is estimated that 150 to 200 deaths and 15 to 20 LTs occur as a result of poisoning each year in England and Wales.

10 Apr 2014

Medical News

Angelica sinensis polysaccharides alleviate neuronal cell injury caused by oxidative stress

Human testes respond differently to endocrine disrupting chemicals

Study: CD206-targeting Manocept platform may provide potential avenues to enhance diagnosis in Kaposi Sarcoma

Lemelson-MIT Program announces winners of National Collegiate Student Prize Competition

Shiseido concludes joint venture agreement to expand Indonesia operations

BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

CNO features in Forbes 2014 list of 50 Most Trustworthy Financial Companies in America

Inserm plays key role in developing European research

Quantum Materials supplies metallic oxide particles to major Asian electronics conglomerate

New discovery opens door to development of new treatments that stop progression of Parkinson's disease

AVEO joins with Biodesix to develop and commercialize ficlatuzumab for treatment of NSCLC

Rite Aid announces acquisition of Houston-based RediClinic

NextGen earns ONC 2014 Edition criteria certification for Emergency Department Solution

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

Sealand Natural Resources expands into new markets to support consumer demands

Spike in mortality after cardiac surgery is associated with 30 days survival measurement

Affordable Care Act may alter costs for Automobile and liability insurance

Life-space mobility reflects physical function and sense of autonomy in older adults

Researchers examine mental health toll exacted on civilians who work with military in war zones

Novel prediction model improves patient outcomes after paracetamol-induced acute liver failure

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News